This study aimed to establish a simple prognostic scoring model based on tumor burden score (TBS) and PIVKA‐II to predict long‐term outcomes of α‐fetoprotein (AFP)‐negative hepatocellular carcinoma (HCC) patients. The gene discussed is AFP; the disease is hepatocellular carcinoma.